Avid Bioservices Inc (CDMO)

[realist1]

RE "human clinical CAR-T+Bavituximab (or betabodies) has been designed by Memorial Sloan Kettering (his Wolchok Lab)"

Insignificant.
All that means is that pre-clinical looked good.
Yup, we know that. We've known that for about 13 or more YEARS now.
All that matters is HUMAN data.
"designed" a human trail doesn't add value to a failed drug.

Breadcrumbs if lucky or nothing up front.
And with PPHM it's ALWAYS the worst outcome that is reality.

I see the stock now slipping into the $3's.
STILL overvalued based on worthless drugs and Avid shrinking NOT growing.
The new boys better ink some new big contracts soon, that's the ONLY thing that will stop the share price decline.